05.12.16
Jill C. Blumhoff has been appointed chief financial officer and vice president of finance at Bioanalytical Systems, Inc. Ms. Blumhoff succeeds Jeffrey Potrzebowski, who has retired from the company.
Ms. Blumhoff joined the company in 2007 as assistant controller and has served as director of finance, tax and IT since 2013. Ms. Blumhoff has been responsible for all aspects of financial reporting and disclosure in addition to leading the company’s efforts in building the financial support structure at BASi. Before joining BASi, she held various roles of increasing responsibility in financial reporting and analysis at Wabash National Corp., and began her career at Ernst & Young LLP.
“Jill is a valued member of the finance team who has been instrumental in guiding BASi during a period of significant change at our company,” said Jacqueline M. Lemke, BASi president and chief executive officer. “Jill’s knowledge and understanding of BASi’s business as well as her leadership of the financial team in support all areas of the operations, will enable BASi to focus on our highest-potential growth opportunities.”
Ms. Blumhoff joined the company in 2007 as assistant controller and has served as director of finance, tax and IT since 2013. Ms. Blumhoff has been responsible for all aspects of financial reporting and disclosure in addition to leading the company’s efforts in building the financial support structure at BASi. Before joining BASi, she held various roles of increasing responsibility in financial reporting and analysis at Wabash National Corp., and began her career at Ernst & Young LLP.
“Jill is a valued member of the finance team who has been instrumental in guiding BASi during a period of significant change at our company,” said Jacqueline M. Lemke, BASi president and chief executive officer. “Jill’s knowledge and understanding of BASi’s business as well as her leadership of the financial team in support all areas of the operations, will enable BASi to focus on our highest-potential growth opportunities.”